1. Home
  2. FULC vs UXIN Comparison

FULC vs UXIN Comparison

Compare FULC & UXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

N/A

Current Price

$3.69

Market Cap

281.1M

Sector

Health Care

ML Signal

N/A

Logo Uxin Limited ADS

UXIN

Uxin Limited ADS

SELL

Current Price

$0.68

Market Cap

226.6M

ML Signal

SELL

Company Overview

Basic Information
Metric
FULC
UXIN
Founded
2015
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
281.1M
226.6M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
FULC
UXIN
Price
$3.69
$0.68
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $3.67
N/A
AVG Volume (30 Days)
★ 1.2M
98.7K
Earning Date
11-12-2026
12-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$59.68
Revenue Next Year
N/A
$71.25
P/E Ratio
★ N/A
$4.05
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$0.71
52 Week High
$15.74
$4.18

Technical Indicators

Market Signals
Indicator
FULC
UXIN
Relative Strength Index (RSI) 45.53 33.80
Support Level $3.62 N/A
Resistance Level $3.81 $1.02
Average True Range (ATR) 0.06 0.08
MACD -0.00 -0.00
Stochastic Oscillator 7.69 4.57

Price Performance

Historical Comparison
FULC
UXIN

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates a car retailer, pioneering industry transformation with production, new retail experiences, and digital empowerment in China. With its inventory-owning model, it provides customers a comprehensive transaction solution that encompasses the entire value chain, ranging from used-car acquisition, inspection, and reconditioning, warehousing, as well as pre-sales and after-sales services. The group offers high-quality and value-for-money used cars as well as superior full suites of services to customers through a reliable, one-stop, and hassle-free transaction experience. It derives revenues from retail vehicle sales, wholesale vehicle sales, and other businesses. The Group generates its revenues in China.

Share on Social Networks: